Dechra Pharmaceuticals PLC 2022 Annual Report Posting Date (6544Z)
15 Septiembre 2022 - 9:28AM
UK Regulatory
TIDMDPH
RNS Number : 6544Z
Dechra Pharmaceuticals PLC
15 September 2022
Thursday, 15 September 2022
Dechra(R) Pharmaceuticals PLC
(the Company)
2022 Annual Report Posting Date
The Company announced last week (on 6 September) that the 2022
Annual Report and Accounts and related documents would be mailed to
registered shareholders on the Monday, 19 September 2022. However,
as this day is being marked as a Bank Holiday in the UK, the
Company wishes to advise shareholders that we now expect to mail
all documentation on Tuesday 20 September 2022.
At the same time, and in accordance with Listing Rule 9.6.1 a
copy of all these documents will be submitted to the National
Storage Mechanism and will be available for viewing.
The 2022 Annual Report and Accounts is already available to view
and download from the Company's investor website.
For further information, please contact:
Melanie Hall, Company Secretary
Dechra Pharmaceuticals PLC
Telephone: 01606 814730
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and
related products business. Our expertise is in the development,
manufacture, marketing and sales of high quality products
exclusively for veterinarians worldwide.
For more information please visit: www.dechra.com
LEI: 213800J4UVB5OWG8VX82
Trademarks
Trademarks appear throughout this document in italics. Dechra
and the Dechra "D" logo are registered trademarks of Dechra
Pharmaceuticals PLC.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ACSUVUSRUBUKAAR
(END) Dow Jones Newswires
September 15, 2022 10:28 ET (14:28 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Dechra Pharmaceuticals (LSE:DPH)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024